Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Accumulated Depreciation & Amortization (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $28.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 12.79% year-over-year to $28.6 million, compared with a TTM value of $28.6 million through Dec 2025, up 12.79%, and an annual FY2025 reading of $28.6 million, up 12.79% over the prior year.
  • Accumulated Depreciation & Amortization was $28.6 million for Q4 2025 at Viemed Healthcare, up from $21.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $28.6 million in Q4 2025 and bottomed at -$65.5 million in Q3 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is -$9.0 million, with a median of $10.0 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization fell 22.79% in 2021, then skyrocketed 125.93% in 2022.
  • Year by year, Accumulated Depreciation & Amortization stood at -$60.3 million in 2021, then surged by 125.93% to $15.6 million in 2022, then surged by 39.87% to $21.9 million in 2023, then rose by 16.04% to $25.4 million in 2024, then increased by 12.79% to $28.6 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for VMD at $28.6 million in Q4 2025, $21.0 million in Q3 2025, and $13.5 million in Q2 2025.